This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

Neurochemical Studies of Early-Onset Alzheimer's Disease — Possible Influence on Treatment

List of authors.
  • Paul T. Francis, Ph.D.,
  • Alan M. Palmer, M.Sc.,
  • Neil R. Sims, Ph.D.,
  • David M. Bowen, Ph.D.,
  • Alan N. Davison, D.Sc.,
  • Margaret M. Esiri, D.M.,
  • David Neary, M.D.,
  • Julie S. Snowden, Ph.D.,
  • and Gordon K. Wilcock, D.M.

Abstract

Multiple neurotransmitter deficits found in recent autopsy studies of patients with Alzheimer's disease may militate against the success of "simple cholinergic replacement" as treatment. To study acetylcholine synthesis, we measured the incorporation of Radio-labeled glucose into the transmitter in temporal-cortex specimens obtained at diagnostic craniotomy in 17 young patients with Alzheimer's disease. Synthesis of acetylcholine was significantly correlated with cognitive impairment. These results are consistent with the view that the deficit in the presynaptic cholinergic system is a relatively early change in the development of the clinical features of the disease. Other alterations in noradrenergic cells, some cortical neurons, postsynaptic cortical receptors, and possibly serotoninergic cells may not be closely associated with Alzheimer's disease. (N Engl J Med 1985; 313:7–11.)

Funding and Disclosures

Supported by grants from the Brain Research Trust, the Medical Research Council, and the Miriam Marks Charitable Trust.

We are indebted to Yvonne Joseph and Gary Stratmann for their excellent technical assistance, to Professor J.A.N. Corsellis and Dr. D.M.A. Mann for help in the collection and classification of some of the samples used in this study, and to Daksha Gandhi for help in preparing the manuscript.

Author Affiliations

From the Miriam Marks Department of Neurochemistry, Institute of Neurology, University of London; the Departments of Neuropathology and Geriatric Medicine, Radcliffe Infirmary, Oxford; and the Department of Neurology, Manchester Royal Infirmary, Manchester, United Kingdom. Address reprint requests to Dr. Bowen at the Institute of Neurology, 33 John's Mews, London WC1N 2NS, United Kingdom, or to Dr. Sims at the Dementia Research Service, Burke Rehabilitation Center, 785 Mamaroneck Ave., White Plains, NY 10605.

Print Subscriber? Activate your online access.